Task: Answer the multiple-choice question.
Question: Which drug exhibits a 17.265\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a.) Cc1c(Cc2ccc3c(c2)OCO3)sc(NC(=O)c2ccccc2)c1C(N)=O
b.) Cc1cc(-c2nn3c(-c4ccccc4)nnc3s2)c2ccccc2n1
c.) COc1ccc(C(=O)N[C@H](C(=O)Nc2nc3ccccc3[nH]2)C(C)C)cc1
d.) COc1ccc(OCc2cc(C(=O)NC(C)Cc3ccccn3)no2)c(Cl)c1
Answer: c. COc1ccc(C(=O)N[C@H](C(=O)Nc2nc3ccccc3[nH]2)C(C)C)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(C(=O)N[C@H](C(=O)Nc2nc3ccccc3[nH]2)C(C)C)cc1
COc1ccc(C(=O)N[C@H](C(=O)Nc2nc3ccccc3[nH]2)C(C)C)cc1
N-[(2S)-1-(1H-benzimidazol-2-ylamino)-3-methyl-1-oxobutan-2-yl]-4-methoxybenzamide